The Detection of HER2 Gene Amplification in Breast Cancer by upQMPSF
- Publish Date: 2017-09-22
Research Abstract:
The amplification of human epidermal growth factor receptor 2 (HER2) gene in breast cancer identifies patients eligible for Trastuzumab therapy. immunohistochemistry (IHC) and/or fluorescent in situ hybridization (FISH) are the only FDA approved techniques for evaluating HER2 status. However, Interobserver variability is still a dilemma
Publishers:
![](https://au.edu.sy/storage/upload/image/person-260-230s/39ekdg9g8td5_image_سامي ازرق.jpeg)
Sami Azrak
![](https://au.edu.sy/images/avatar.jpeg)
Batool Alassar
![](https://au.edu.sy/images/avatar.jpeg)
Thaer Khoury
- Link Journal:
Journal of Genetics and Genetic Engineering